Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Taiho Ventures

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 24
Average round size
The average size of a deal this fund participated in
Portfolio companies 17
Rounds per year 4.00
Lead investments 5
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 5
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical

The company was established in North America in United States. The main office of represented VC is situated in the California City.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Taiho Ventures, startups are often financed by The Column Group, OrbiMed, Foresite Capital. The meaningful sponsors for the fund in investment in the same round are The Column Group, OrbiMed, Foresite Capital. In the next rounds fund is usually obtained by The Column Group, OrbiMed, Invus.

The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2019. The top amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 50 - 100 millions dollars. Opposing the other organizations, this Taiho Ventures works on 1 percentage points more the average amount of lead investments.

Among the most popular portfolio startups of the fund, we may highlight Axial Biotherapeutics, Breakpoint Therapeutics, Harpoon Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Biotechnology. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Taiho Ventures:
Typical Co-investors
Taiho Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Taiho Ventures:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Access National Bank Reston, United States, Virginia
Amana Chiyoda, Japan
Blue Stone Capital Management Binjiang, China, Jiangxi
Creative Artists Agency California, Los Angeles, United States
eXeed Technology HaMerkaz, Israel, Savyon
Fuchengwan Touzi China, Guangdong, Tianjin
JVCKenwood Corp. Japan, Kanagawa Prefecture, Yokohama
Kleinwort Benson England, London, United Kingdom
Megunticook Fund -
Nobska Ventures Maryland, Stevenson, United States
NorthPoint Communications Group California, San Francisco, United States
Nurmiranta Holdings -
Peptidream -
Qingyan Lushi Investment China, Guangdong, Tianjin
Runwu Konggu Beijing, China, Haidian
TechnoCap Canada, Montréal, Quebec
The Mark Foundation for Cancer Research -
The Pags Group -
VILLAGEx District of Columbia, United States, Washington
Wemind -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Dren Bio

Health Care
Life Science
$65M14 Jun 2022 California, United States

Transition Bio

Health Care
Health Diagnostics
$50M02 Jun 2022 Cambridge, Massachusetts, United States


$30M26 Jan 2022 Minhang, Shanghai, China

Parthenon Therapeutics

Life Science
$65M03 Nov 2021 Cambridge, Massachusetts, United States

Axial Biotherapeutics

$37M13 Oct 2021 Massachusetts, United States

Anavo Therapeutics

Life Science
$23M22 Apr 2021 Leiden, South Holland, Netherlands

$80M24 Feb 2021 Cambridge, Massachusetts, United States

Werewolf Therapeutics

Life Science
$72M07 Jan 2021 Cambridge, Massachusetts, United States

Dren Bio

Health Care
Life Science
$60M16 Oct 2020 California, United States
Theolytics Expands Series A Funding Round

– Theolytics, an Oxford, UK-based developer of a library of potential adenovirus product candidates and breakthrough bioselection systems, raised new funding from M Ventures.
– Funding was joined by Epidarex Capital and Taiho Ventures in an extension to the Series A financing.
– The expanded Series A funding will support the progress of internal programmes in ovarian cancer, and a second cancer indication in addition to further advancing the company’s technology platforms.

Orna Therapeutics Launches With $80M Series A

– Orna Therapeutics, a biotechnology company dedicated to RNA therapeutics (oRNAs), announced the completion of its $80m Series A financing.
– The financing was co-led by MPM Capital, Taiho Ventures, and F2 Ventures, with participation from leading strategic investors: Kite, a Gilead Company, Bristol Myers Squibb, Astellas Venture Management, Novartis Institutes for Biomedical Research, and the PAGS Group.
– Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way disease is treated.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Taiho Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: